Annual report pursuant to Section 13 and 15(d)

Other Assets

v3.22.4
Other Assets
 12 Months Ended
Dec. 31, 2022
Other Assets [Abstract]  
Other Assets Other Assets
Other assets consisted of the following (in millions):
As of December 31,
2022 2021
Non-trade receivables, net $ 65  $ 57 
Right-of-use assets 62  79 
Deferred costs 49  53 
Capitalized contract costs (a)
42  36 
Deferred tax asset 23  25 
Deposits 22  20 
Investments 18  21 
Marketable securities 12  27 
Derivatives 12  2 
Tax receivables 3  5 
Other 16  14 
$ 324  $ 339 
(a)Includes certain direct and incremental selling costs in connection with VOI trial package, incentive, subscription, and exchange–related revenues. See Note 3—Revenue Recognition for additional details.